Replies to post #5264 on Ekso Bionics Holdings Inc (EKSO)

[Rhetorical]

United States Special Operations Command remains highly invested in the TALOS program, calling it their “top research-and-development priority.”

SOCOM Comments

This isn't Miller saying that his own top priority is TALOS, this is Miller saying that SOCOM's top R&D priority is TALOS. In 2016, over a half billion dollars were budgeted for SOCOM R&D. Being number one on this list could be a huge windfall for Ekso assuming they're continuing to produce the chassis as they have in the past.

A one year delay on TALOS demonstration hurts to see, especially with Ekso struggling. That being said, James' above comment is very strong. Having been the Chief of Staff of SOCOM Europe before becoming the TALOS joint acquisition director, his resume backs up his comments.

Ideologically, Ekso is my favorite investment play. I think they have the potential for enormous growth. Out of all the exoskeleton companies, I think their technology is the most advanced.

That being said, the company's accumulated deficits are getting very high. Debt is still low, but it's totally unclear to me when or if Ekso will turn a net profit. A path to this point needs to become visible before I expect the stock price to rise drastically.

I don't currently hold EKSO stock.